Kentaro Hayashida
林田, 健太郎
VIAF ID: 109766715 (Personal)
Permalink: http://viaf.org/viaf/109766715
Preferred Forms
- 100 0 _ ‡a Kentaro Hayashida
- 100 1 _ ‡a 林田, 健太郎
- 100 1 _ ‡a 林田, 健太郎
4xx's: Alternate Name Forms (6)
Works
Title | Sources |
---|---|
Esueichidi intabenshon konpurito gaido. | |
Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis | |
Hybrid Operating Rooms for Transcatheter Aortic Valve Replacement: A Must-Have or Nice to Have? | |
In-Stent Dissection Causes No Flow During Percutaneous Coronary Intervention. | |
Incidence, Predictors, and Mid-Term Outcomes of Possible Leaflet Thrombosis After TAVR. | |
Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury | |
Intensive statin therapy stabilizes C-reactive protein, but not chemokine in stable coronary artery disease treated with an everolimus-eluting stent. | |
Intracardiac echocardiography for percutaneous closure of atrial septal defects: initial experiences in Japan | |
Is elevation of N-terminal pro-B-type natriuretic peptide at discharge associated with 2-year composite endpoint of all-cause mortality and heart failure hospitalisation after transcatheter aortic valve implantation? Insights from a multicentre prosp | |
Is postdilatation useful after implantation of the Edwards valve? | |
Lesion morphological classification by OCT to predict therapeutic efficacy after balloon pulmonary angioplasty in CTEPH | |
Malnutrition among elderly patients with severe aortic stenosis | |
Multidisciplinary approach to the treatment of cardiac AA amyloidosis and aortic stenosis due to Castleman's disease: a hybrid therapy with tocilizumab and aortic valve replacement | |
Nocturnal intermittent hypoxia and short sleep duration are independently associated with elevated C-reactive protein levels in patients with coronary artery disease. | |
[Percutaneous aortic valve implantation: results and perspectives] | |
Percutaneous Occlusion of Patent Ductus Arteriosus for an Elderly Patient With Refractory Congestive Heart Failure | |
Percutaneous WATCHMAN Left Atrial Appendage Closure for Japanese Patients With Nonvalvular Atrial Fibrillation at Increased Risk of Thromboembolism - First Results From the SALUTE Trial | |
Physical frailty in older people with severe aortic stenosis. | |
Potential mechanism of annulus rupture during transcatheter aortic valve implantation. | |
Pre-Existing Right Bundle Branch Block Increases Risk for Death After Transcatheter Aortic Valve Replacement With a Balloon-Expandable Valve. | |
The Prevalence of Clinically Significant Ischemia in Patients Undergoing Percutaneous Coronary Intervention: A Report from the Multicenter Registry | |
Prognostic impact of postprocedure stroke volume in patients with low-gradient aortic stenosis | |
Prognostic implications of optimal medical therapy in patients undergoing percutaneous coronary intervention for acute coronary syndrome in octogenarians. | |
Real-World Use and Appropriateness of Coronary Interventions for Chronic Total Occlusion (from a Japanese Multicenter Registry). | |
Rebuttal: Comparison of multislice computed tomography findings between bicuspid and tricuspid aortic valves before and after transcatheter aortic valve implantation | |
Renal function-based contrast dosing predicts acute kidney injury following transcatheter aortic valve implantation | |
Response by Yamamoto et al to Letter Regarding Article, "Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement". | |
Risk stratification using lean body mass in patients undergoing transcatheter aortic valve replacement. | |
Safety and efficacy of minimalist approach in transfemoral transcatheter aortic valve replacement: insights from the Optimized transCathEter vAlvular interventioN-Transcatheter Aortic Valve Implantation | |
SHD (Shin kozo shikkan) Chiryo update. | |
SHD(心構造疾患)治療UPDATE | |
SHDインターベンションコンプリートガイド = Complete Guide to Structural Heart Disease Intervention | |
Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertension | |
Streamlining the learning process for TAVI: Insight from a comparative analysis of the OCEAN-TAVI and the massy registries | |
Subclinical leaflet thickening and stent frame geometry in self-expanding transcatheter heart valves | |
Tavi jissen manyuaru. | |
Transapical Approach: Learn From the Past, Move Toward the Future | |
Transcatheter Aortic Valve Implantation in a Patient with Severe, Precapillary Pulmonary Arterial Hypertension. | |
Transcatheter aortic valve replacement with Evolut R versus Sapien 3 in Japanese patients with a small aortic annulus: The OCEAN-TAVI registry | |
Transfemoral aortic valve implantation in patients with an annulus dimension suitable for either the Edwards valve or the CoreValve | |
Transfemoral aortic valve implantation new criteria to predict vascular complications | |
Transradial complex coronary interventions using a five-in-six system | |
Update on the clinical impact of mild aortic regurgitation after transcatheter aortic valve implantation: Insights from the Japanese multicenter OCEAN-TAVI registry | |
Usefulness of a Simple Clinical Risk Prediction Method, Modified ACEF Score, for Transcatheter Aortic Valve Implantation | |
Utility of the reverse wire technique in multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation |